<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Dronabinol - Complete Profile</title>
    <link rel="stylesheet" href="/Dyo-s-Dubious-Domain/style.css">
</head>

<body class="
  
  
  
  ">
    <header class="page-header">
  <div class="container">
    <div class="page-header__content">
      <div class="logo-container">
        <a href="/Dyo-s-Dubious-Domain/" class="site-title">Dyo's Dubious Domain</a>
      </div>
      
      <nav>
        <ul role="list" class="nav-list flex-group">
          <li>
            <a href="/Dyo-s-Dubious-Domain/">Home</a>
          </li>
          <li>
            <a href="/Dyo-s-Dubious-Domain/dyos-domain/">Dyo's Domain</a>
          </li>
          <li>
            <a href="/Dyo-s-Dubious-Domain/about/">About</a>
          </li>
          <li>
            <a href="/Dyo-s-Dubious-Domain/profile/">My Profile</a>
          </li>
         
        </ul>
      </nav>
    </div>
    
    <!-- Search Bar - Now underneath header -->
    <div class="search-container">
      <input type="text" id="search-input" placeholder="Search substances..." class="search-input" />
      <div id="search-results" class="search-results" style="display: none;"></div>
    </div>
  </div>
</header>

    <main>
      
<div class="substance-profile-header">
  <div class="container">
    <nav class="breadcrumb">
      <a href="/dyos-domain/">Dyo's Domain</a> ‚Üí <a href="/dyos-domain/cannabinoids/">Cannabinoids</a> ‚Üí <span>Dronabinol</span>
    </nav>
    
    <div class="substance-hero">
      <div class="substance-info">
        <h1>üåø Dronabinol</h1>
        <h2 class="chemical-name">(-)-trans-Œî‚Åπ-tetrahydrocannabinol</h2>
         <!-- Add to Profile Button -->
        <button id="add-to-profile-btn" class="add-to-profile-btn not-in-profile" 
                data-substance="Dronabinol" 
                data-category="Cannabinoids" 
                data-chemical="(-)-trans-Œî‚Åπ-tetrahydrocannabinol">
          + Add to My Profile
        </button>
        
        <div class="alternative-names">
          <h3>Alternative Names & Slang</h3>
          <div class="names-grid">
            <div class="name-category">
              <h4>Brand Names</h4>
              <span>Marinol</span> ‚Ä¢ <span>Syndros</span> ‚Ä¢ <span>Cesamet</span>
            </div>
            <div class="name-category">
              <h4>Chemical Names</h4>
              <span>Delta-9-THC</span> ‚Ä¢ <span>Œî‚Åπ-THC</span> ‚Ä¢ <span>THC</span> ‚Ä¢ <span>Tetrahydrocannabinol</span>
            </div>
            <div class="name-category">
              <h4>Medical/Clinical</h4>
              <span>Synthetic THC</span> ‚Ä¢ <span>Pharmaceutical Cannabis</span> ‚Ä¢ <span>Medical Marijuana Pill</span>
            </div>
            <div class="name-category">
              <h4>Regulatory</h4>
              <span>Schedule III</span> ‚Ä¢ <span>Controlled Substance</span> ‚Ä¢ <span>Prescription Cannabis</span>
            </div>
          </div>
        </div>
        
        <div class="substance-meta-large">
          <span class="category cannabinoid">Cannabinoid</span>
          <span class="legal-status schedule-3">Schedule III</span>
          <span class="duration long">2-8 hours</span>
        </div>
      </div>
      
      <div class="substance-visual">
        <div class="substance-image">
          <img src="/assets/substances/dronabinol.jpg" alt="Dronabinol capsules" class="substance-photo">
        </div>
        <div class="molecule-structure">
          <div class="structure-placeholder">
            <p>üß¨ C‚ÇÇ‚ÇÅH‚ÇÉ‚ÇÄO‚ÇÇ</p>
            <p>MW: 314.46 g/mol</p>
          </div>
        </div>
      </div>
    </div>
  </div>
</div>

<div class="container">
  
  <div class="profile-grid">
    
    <div class="profile-section identification">
      <h3>üîç Physical Identification</h3>
      <div class="identification-info">
        <div class="pure-form">
          <h4>Pharmaceutical Dronabinol</h4>
          <ul>
            <li><strong>Appearance:</strong> Viscous, amber-colored oil in gelatin capsules</li>
            <li><strong>Capsule colors:</strong> Various (2.5mg: white, 5mg: dark brown, 10mg: orange)</li>
            <li><strong>Texture:</strong> Sticky, resinous oil when extracted from capsule</li>
            <li><strong>Odor:</strong> Distinctive cannabis-like, pungent, herbal</li>
            <li><strong>Taste:</strong> Bitter, herbal, cannabis-like (usually in sesame oil carrier)</li>
            <li><strong>Solubility:</strong> Lipophilic - dissolves in fats/oils, poorly water-soluble</li>
          </ul>
        </div>
        
        <div class="street-forms">
          <h4>Medical Formulations</h4>
          <ul>
            <li><strong>Marinol capsules:</strong> 2.5mg, 5mg, 10mg gelatin capsules</li>
            <li><strong>Syndros oral solution:</strong> Liquid formulation with ethanol</li>
            <li><strong>Carrier oils:</strong> Usually suspended in sesame oil or ethanol</li>
            <li><strong>Generic versions:</strong> Various manufacturers, same active ingredient</li>
          </ul>
        </div>
        
        <div class="adulterants-warning">
          <h4>‚ö†Ô∏è Verification Notes</h4>
          <p><strong>Prescription only:</strong> Legitimate dronabinol only available through licensed pharmacies</p>
          <p><strong>Counterfeits:</strong> Rare but possible - verify through pharmacy chains</p>
          <p><strong>Purity:</strong> Pharmaceutical grade ensures consistent dosing vs. plant cannabis</p>
        </div>
      </div>
    </div>
    
    <div class="profile-section dosage">
      <h3>üíä Dosage Guidelines</h3>
      <div class="dosage-chart">
        <div class="dose-range threshold">
          <span class="range-label">Threshold</span>
          <span class="dose-amount">1-2.5mg</span>
          <div class="dose-bar"></div>
        </div>
        <div class="dose-range light">
          <span class="range-label">Light</span>
          <span class="dose-amount">2.5-5mg</span>
          <div class="dose-bar"></div>
        </div>
        <div class="dose-range common">
          <span class="range-label">Common</span>
          <span class="dose-amount">5-10mg</span>
          <div class="dose-bar"></div>
        </div>
        <div class="dose-range strong">
          <span class="range-label">Strong</span>
          <span class="dose-amount">10-20mg</span>
          <div class="dose-bar"></div>
        </div>
        <div class="dose-range heavy">
          <span class="range-label">Heavy</span>
          <span class="dose-amount">20mg+</span>
          <div class="dose-bar"></div>
        </div>
      </div>
      
      <div class="dosage-details">
        <h4>Medical Dosage Guidelines</h4>
        <ul>
          <li><strong>Appetite stimulation:</strong> 2.5mg twice daily, before lunch and dinner</li>
          <li><strong>Nausea/vomiting:</strong> 5mg 1-3 hours before chemotherapy</li>
          <li><strong>Elderly patients:</strong> Start with 1.25mg once daily in evening</li>
          <li><strong>Tolerance:</strong> Develops within days to weeks of regular use</li>
          <li><strong>Titration:</strong> Increase by 2.5mg increments as needed</li>
          <li><strong>Maximum:</strong> Usually not exceeding 20mg/day in divided doses</li>
        </ul>
      </div>
      
      <p class="dosage-note"><strong>Medical Note:</strong> Dronabinol should only be used under medical supervision. Onset is delayed compared to smoked cannabis - wait 2+ hours before additional dosing.</p>
    </div>

    <div class="profile-section effects">
      <h3>‚ú® Effects Profile</h3>
      
      <div class="effects-timeline">
        <h4>Timeline (Oral)</h4>
        <div class="timeline-item">
          <span class="time">T+0:30-2:00</span>
          <span class="effect">Onset - subtle mood changes, appetite increase</span>
        </div>
        <div class="timeline-item">
          <span class="time">T+2:00-4:00</span>
          <span class="effect">Peak - full psychoactive effects, strong appetite</span>
        </div>
        <div class="timeline-item">
          <span class="time">T+4:00-8:00</span>
          <span class="effect">Plateau - sustained therapeutic effects</span>
        </div>
        <div class="timeline-item">
          <span class="time">T+8:00-12:00</span>
          <span class="effect">Comedown - gradual return to baseline</span>
        </div>
      </div>

      <div class="effects-categories">
        <div class="effect-category positive">
          <h4>‚úÖ Therapeutic Effects</h4>
          <ul>
            <li>Significant appetite stimulation</li>
            <li>Anti-nausea and anti-vomiting</li>
            <li>Mood elevation and euphoria</li>
            <li>Pain relief (analgesic)</li>
            <li>Reduced anxiety and agitation</li>
            <li>Improved sleep quality</li>
          </ul>
        </div>
        
        <div class="effect-category negative">
          <h4>‚ùå Side Effects</h4>
          <ul>
            <li>Dizziness and lightheadedness</li>
            <li>Dry mouth (xerostomia)</li>
            <li>Red eyes (conjunctival injection)</li>
            <li>Cognitive impairment and confusion</li>
            <li>Anxiety or paranoia (dose-dependent)</li>
            <li>Drowsiness and sedation</li>
          </ul>
        </div>
      </div>
    </div>

    <div class="profile-section pharmacology">
      <h3>üß† Pharmacology & Neuroscience</h3>
      <div class="pharma-details">
        <h4>Primary Mechanism of Action</h4>
        <p>Dronabinol is a partial agonist at cannabinoid CB1 and CB2 receptors, primarily acting in the central nervous system (CB1) and immune system (CB2). It mimics the action of endogenous cannabinoids like anandamide, modulating neurotransmitter release and cellular signaling pathways throughout the endocannabinoid system.</p>
        
        <h4>Detailed Receptor Pharmacology</h4>
        <div class="receptor-table">
          <div class="receptor-row">
            <span class="receptor-name"><strong>CB1 receptors</strong></span>
            <span class="affinity">High affinity partial agonist (Ki: 5-80 nM)</span>
            <span class="function">Psychoactive effects, appetite, memory, motor control</span>
          </div>
          <div class="receptor-row">
            <span class="receptor-name"><strong>CB2 receptors</strong></span>
            <span class="affinity">Moderate affinity partial agonist</span>
            <span class="function">Anti-inflammatory, immune modulation</span>
          </div>
          <div class="receptor-row">
            <span class="receptor-name"><strong>5-HT3 receptors</strong></span>
            <span class="affinity">Antagonist activity</span>
            <span class="function">Anti-nausea effects, especially chemotherapy-induced</span>
          </div>
          <div class="receptor-row">
            <span class="receptor-name"><strong>TRPV1 channels</strong></span>
            <span class="affinity">Weak agonist activity</span>
            <span class="function">Pain modulation, temperature sensation</span>
          </div>
          <div class="receptor-row">
            <span class="receptor-name"><strong>GPR55 receptors</strong></span>
            <span class="affinity">Antagonist activity</span>
            <span class="function">Bone development, neuropathic pain</span>
          </div>
        </div>

        <h4>Metabolism & Pharmacokinetics</h4>
        <div class="metabolism-details">
          <p><strong>Primary Pathway:</strong> Hepatic metabolism via CYP2C9, CYP2C19, and CYP3A4</p>
          <p><strong>Active Metabolite:</strong> 11-hydroxy-THC (more potent than parent compound)</p>
          <p><strong>Inactive Metabolite:</strong> 11-nor-9-carboxy-THC (detected in drug tests)</p>
          <p><strong>Half-life:</strong> 25-36 hours (highly lipophilic, accumulates in fatty tissue)</p>
          <p><strong>Bioavailability:</strong> 10-20% oral (first-pass metabolism)</p>
          <p><strong>Peak plasma:</strong> 1-6 hours (highly variable)</p>
          <p><strong>Duration:</strong> 4-8 hours psychoactive, 24+ hours detectable</p>
        </div>

        <h4>Endocannabinoid System Interaction</h4>
        <div class="neurotoxicity-info">
          <p><strong>CB1 distribution:</strong> Concentrated in brain regions controlling appetite, memory, and motor function</p>
          <p><strong>Appetite regulation:</strong> Acts on hypothalamic circuits controlling hunger and satiety</p>
          <p><strong>Memory effects:</strong> Disrupts hippocampal-dependent memory formation</p>
          <p><strong>Motor control:</strong> Affects basal ganglia and cerebellum coordination</p>
        </div>

        <h4>Unique Pharmacological Properties</h4>
        <ul>
          <li><strong>Biphasic effects:</strong> Low doses stimulating, high doses sedating</li>
          <li><strong>Tissue accumulation:</strong> Highly lipophilic, stores in fat for weeks</li>
          <li><strong>Individual variation:</strong> Metabolism varies significantly between patients</li>
          <li><strong>Food interaction:</strong> Absorption increased 2.5-3x when taken with fatty meal</li>
          <li><strong>Tolerance development:</strong> Rapid tolerance to psychoactive but not therapeutic effects</li>
        </ul>
      </div>
    </div>

    <div class="profile-section safety">
      <h3>‚ö†Ô∏è Safety & Harm Reduction</h3>
      
      <div class="safety-grid">
        <div class="safety-item critical">
          <h4>üö® Critical Warnings</h4>
          <ul>
            <li><strong>Driving impairment:</strong> Significantly affects reaction time and judgment</li>
            <li><strong>Psychiatric conditions:</strong> Can exacerbate psychosis, mania, depression</li>
            <li><strong>Cardiovascular stress:</strong> Can increase heart rate and blood pressure</li>
            <li><strong>Delayed onset:</strong> Easy to accidentally overdose due to slow onset</li>
          </ul>
        </div>
        
        <div class="safety-item precautions">
          <h4>üõ°Ô∏è Precautions</h4>
          <ul>
            <li>Start with lowest possible dose (1-2.5mg)</li>
            <li>Wait at least 2 hours before additional dosing</li>
            <li>Take with food to enhance absorption consistency</li>
            <li>Avoid alcohol and other CNS depressants</li>
            <li>Don't drive or operate machinery</li>
            <li>Store securely - controlled substance</li>
          </ul>
        </div>
      </div>

      <div class="contraindications">
        <h4>üö´ Contraindications</h4>
        <p><strong>Do not use if you have:</strong> History of psychosis, schizophrenia, severe heart disease, substance abuse history, or hypersensitivity to cannabinoids or sesame oil.</p>
      </div>
    </div>

    <div class="profile-section interactions">
      <h3>‚öóÔ∏è Drug Interactions</h3>
      
      <div class="interaction-levels">
        <div class="interaction dangerous">
          <h4>üî¥ Dangerous</h4>
          <ul>
            <li><strong>CNS Depressants:</strong> Alcohol, benzodiazepines, opioids - increased sedation</li>
            <li><strong>Psychostimulants:</strong> May mask stimulant effects, cardiovascular stress</li>
            <li><strong>Anticholinergics:</strong> Increased risk of confusion and delirium</li>
          </ul>
        </div>
        
        <div class="interaction risky">
          <h4>üü° Risky</h4>
          <ul>
            <li><strong>CYP2C9 inhibitors:</strong> Fluconazole, amiodarone - increased THC levels</li>
            <li><strong>CYP3A4 inhibitors:</strong> Ketoconazole, erythromycin - prolonged effects</li>
            <li><strong>Anticonvulsants:</strong> May lower seizure threshold</li>
            <li><strong>Warfarin:</strong> May increase bleeding risk</li>
          </ul>
        </div>
        
        <div class="interaction caution">
          <h4>üü† Use Caution</h4>
          <ul>
            <li><strong>Antidepressants:</strong> May enhance mood effects or cause confusion</li>
            <li><strong>Antipsychotics:</strong> May antagonize antipsychotic effects</li>
            <li><strong>Muscle relaxants:</strong> Additive sedation and motor impairment</li>
          </ul>
        </div>
      </div>
    </div>

    <div class="profile-section legal">
      <h3>‚öñÔ∏è Legal Status</h3>
      <div class="legal-info">
        <div class="legal-jurisdictions">
          <div class="jurisdiction">
            <h4>üá∫üá∏ United States</h4>
            <p><strong>Schedule III</strong> - Legal by prescription only. Lower abuse potential than Schedule I/II. Prescriptions limited to 5 refills within 6 months.</p>
          </div>
          <div class="jurisdiction">
            <h4>üá¨üáß United Kingdom</h4>
            <p><strong>Class B, Schedule 2</strong> - Available as prescription medicine (Nabilone similar compound available)</p>
          </div>
          <div class="jurisdiction">
            <h4>üá®üá¶ Canada</h4>
            <p><strong>Prescription Medicine</strong> - Available through Health Canada's Special Access Programme</p>
          </div>
          <div class="jurisdiction">
            <h4>üá©üá™ Germany</h4>
            <p><strong>Prescription Cannabis</strong> - Available through medical cannabis program since 2017</p>
          </div>
        </div>
        
        <div class="therapeutic-status">
          <h4>üè• FDA-Approved Uses</h4>
          <p><strong>Primary indications:</strong> Anorexia associated with weight loss in AIDS patients, and nausea/vomiting associated with cancer chemotherapy in patients who have failed conventional antiemetic treatments.</p>
        </div>
      </div>
    </div>

    <div class="profile-section history">
      <h3>üìö History & Culture</h3>
      
      <div class="history-timeline">
        <div class="history-event">
          <span class="year">1964</span>
          <p>THC first isolated and synthesized by Raphael Mechoulam in Israel</p>
        </div>
        <div class="history-event">
          <span class="year">1985</span>
          <p>Marinol (dronabinol) approved by FDA for chemotherapy-induced nausea</p>
        </div>
        <div class="history-event">
          <span class="year">1992</span>
          <p>FDA approval expanded to include AIDS-related anorexia and wasting</p>
        </div>
        <div class="history-event">
          <span class="year">1999</span>
          <p>Rescheduled from Schedule II to Schedule III due to low abuse potential</p>
        </div>
        <div class="history-event">
          <span class="year">2016</span>
          <p>Syndros (liquid dronabinol) approved as alternative to capsules</p>
        </div>
        <div class="history-event">
          <span class="year">2018</span>
          <p>Generic versions of dronabinol approved, reducing cost barriers</p>
        </div>
      </div>

      <div class="cultural-impact">
        <h4>Medical Breakthrough</h4>
        <p>Dronabinol represents the first cannabis-derived compound to gain mainstream medical acceptance, paving the way for medical marijuana programs and pharmaceutical cannabis research. It demonstrated that cannabis components could be studied, standardized, and prescribed like conventional medicines.</p>
      </div>
    </div>

    <div class="profile-section research">
      <h3>üî¨ Current Research</h3>
      
      <div class="research-areas">
        <div class="research-item">
          <h4>Cancer Cachexia</h4>
          <p>Ongoing studies examining dronabinol's effectiveness in treating cancer-related weight loss and muscle wasting beyond appetite stimulation.</p>
        </div>
        
        <div class="research-item">
          <h4>PTSD and Sleep Disorders</h4>
          <p>Clinical trials investigating dronabinol for PTSD-related nightmares and sleep disturbances in veterans and trauma survivors.</p>
        </div>
        
        <div class="research-item">
          <h4>Epilepsy and Seizures</h4>
          <p>Research into THC's anticonvulsant properties, particularly in treatment-resistant epilepsy syndromes.</p>
        </div>
        
        <div class="research-item">
          <h4>Opioid Reduction</h4>
          <p>Studies examining dronabinol as an adjunct therapy to reduce opioid requirements in chronic pain management.</p>
        </div>
      </div>
    </div>

  </div>

  <div class="substance-resources">
    <h3>üìñ Additional Resources</h3>
    <div class="resources-grid">
      <div class="resource-item">
        <h4>Medical Information</h4>
        <ul>
          <li><a href="https://www.fda.gov/">FDA Orange Book</a> - Official prescribing information</li>
          <li><a href="https://dailymed.nlm.nih.gov/">DailyMed</a> - Current medication guides</li>
          <li><a href="https://www.drugs.com/">Drugs.com</a> - Patient information and interactions</li>
        </ul>
      </div>
      
      <div class="resource-item">
        <h4>Research & Education</h4>
        <ul>
          <li><a href="https://www.projectcbd.org/">Project CBD</a> - Cannabis research and education</li>
          <li><a href="https://www.leafly.com/">Leafly</a> - Cannabis information and effects</li>
          <li><a href="https://norml.org/">NORML</a> - Legal status and medical access</li>
        </ul>
      </div>
      
      <div class="resource-item">
        <h4>Patient Support</h4>
        <ul>
          <li><a href="https://www.cancer.org/">American Cancer Society</a> - Cancer patient resources</li>
          <li><a href="https://www.thebody.com/">TheBody.com</a> - HIV/AIDS patient information</li>
          <li><a href="https://patients4medicalmarijuana.wordpress.com/">Patients for Medical Cannabis</a> - Patient advocacy</li>
        </ul>
      </div>
    </div>
  </div>

</div>
    </main>
     <div class="footer-divider"></div>
<footer class="site-footer">
  
</footer>




<footer class="site-footer">
  
  </svg>
    <img src="/assets/logo.svg" alt="My Logo" class="logo">
     <p>¬© 2025 Uwaniumnya. Highly Illegal.</p>
  </footer>

  

    <!-- Search Scripts -->
    <script src="/Dyo-s-Dubious-Domain/js/lunr.min.js"></script>
    <script src="/Dyo-s-Dubious-Domain/assets/js/search.js"></script>
    <script src="/Dyo-s-Dubious-Domain/assets/js/substance-integration.js"></script>
    <script src="/Dyo-s-Dubious-Domain/assets/js/profile.js"></script>
    <script src="/Dyo-s-Dubious-Domain/assets/js/friends.js"></script>
</body>
</html>